Abstract

The majority of patients recur after resection of colorectal liver metastases (CRLM). Patients with CRLM displaying a desmoplastic histopathological growth pattern (dHGP) have a better prognosis and lower probability of recurrence than patients with non-dHGP CRLM. The current study evaluates the impact of HGP type on the pattern and treatment of recurrences after first resection of CRLM. A retrospective cohort study was performed, including patients with known HGP type after complete resection of CRLM. All patients were treated between 2000 and 2015. The HGP was determined on the CRLM resected at first partial hepatectomy. The prognostic value of HGPs, in terms of survival outcome, in the current patient cohort were previously published. In total 690 patients were included, of which 492 (71%) developed recurrent disease. CRLM displaying dHGP were observed in 103 patients (21%). Amongst patients with dHGP CRLM diagnosed with recurrent disease, more liver-limited recurrences were seen (43% vs. 31%, p = 0.030), whereas patients with non-dHGP more often recurred at multiple locations (34% vs. 19%, p = 0.005). Patients with dHGP CRLM were more likely to undergo curatively intended local treatment for recurrent disease (adjusted odds ratio: 2.37; 95% confidence interval (CI) [1.46–3.84]; p < 0.001) compared to patients with non-dHGP. The present study demonstrates that liver-limited disease recurrence after complete resection of CRLM is more often seen in patients with dHGP, whereas patients with non-dHGP more frequently experience multi-organ recurrence. Recurrences in patients with dHGP at first CRLM resection are more likely to be salvageable by local treatment modalities, but no prognostic impact of HGPs after salvage therapy for recurrent disease was found.

Highlights

  • After hepatic resection for colorectal liver metastases (CRLM) the majority of patients experiences recurrence of disease

  • 40% of the patients with recurrent disease is again eligible for local treatment modalities [4, 6,7,8]

  • We recently described the largest patient cohort to date and found that the desmoplastic Histopathological growth patterns (HGPs) is associated with favourable overall survival, progression free survival compared to its non-desmoplastic counterpart [23]

Read more

Summary

Introduction

After hepatic resection for colorectal liver metastases (CRLM) the majority of patients experiences recurrence of disease. 40% of the patients with recurrent disease is again eligible for local treatment modalities [4, 6,7,8]. If disease biology allows the recurrence to be treated locally again, survival outcomes similar to the first local treatment of metastases are seen [1, 4, 6,7,8,9,10,11,12,13]. In case of a recurrence not amenable to local treatment prognosis is limited [4, 7, 8, 13]. Clinical risk factors currently used for the prediction of prognosis after first hepatic resection for CRLM, have not proven useful in prognostication after repeat resection for recurrent CLRM [14]

Objectives
Methods
Results
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.